174 related articles for article (PubMed ID: 7669641)
1. Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens.
Tokura Y; Yagi H; Ohshima A; Kurokawa S; Wakita H; Yokote R; Shirahama S; Furukawa F; Takigawa M
Br J Dermatol; 1995 Jul; 133(1):6-12. PubMed ID: 7669641
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins.
Tokura Y; Heald PW; Yan SL; Edelson RL
J Invest Dermatol; 1992 Jan; 98(1):33-7. PubMed ID: 1728639
[TBL] [Abstract][Full Text] [Related]
3. CD7-positive Sézary syndrome with a Th1 cytokine profile.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
[TBL] [Abstract][Full Text] [Related]
4. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.
Jackow CM; Cather JC; Hearne V; Asano AT; Musser JM; Duvic M
Blood; 1997 Jan; 89(1):32-40. PubMed ID: 8978274
[TBL] [Abstract][Full Text] [Related]
5. A restricted clonal T-cell receptor αβ repertoire in Sézary syndrome is indicative of superantigenic stimulation.
van der Fits L; Sandberg Y; Darzentas N; Zoutman WH; Tielemans D; Wolvers-Tettero IL; Vermeer MH; Langerak AW
Br J Dermatol; 2011 Jul; 165(1):78-84. PubMed ID: 21410672
[TBL] [Abstract][Full Text] [Related]
6. T-cell proliferation to superantigen-releasing Staphylococcus aureus by MHC class II-bearing keratinocytes under protection from bacterial cytolysin.
Tokura Y; Furukawa F; Wakita H; Yagi H; Ushijima T; Takigawa M
J Invest Dermatol; 1997 Apr; 108(4):488-94. PubMed ID: 9077479
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome.
Talpur R; Bassett R; Duvic M
Br J Dermatol; 2008 Jul; 159(1):105-12. PubMed ID: 18489588
[TBL] [Abstract][Full Text] [Related]
8. Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis.
Yokote R; Tokura Y; Furukawa F; Takigawa M
Arch Dermatol Res; 1995; 287(5):443-7. PubMed ID: 7625854
[TBL] [Abstract][Full Text] [Related]
9. Skin colonization by superantigen-producing Staphylococcus aureus in Egyptian patients with atopic dermatitis and its relation to disease severity and serum interleukin-4 level.
Nada HA; Gomaa NI; Elakhras A; Wasfy R; Baker RA
Int J Infect Dis; 2012 Jan; 16(1):e29-33. PubMed ID: 22040925
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis.
Bunikowski R; Mielke ME; Skarabis H; Worm M; Anagnostopoulos I; Kolde G; Wahn U; Renz H
J Allergy Clin Immunol; 2000 Apr; 105(4):814-9. PubMed ID: 10756234
[TBL] [Abstract][Full Text] [Related]
11. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
Ferry T; Thomas D; Perpoint T; Lina G; Monneret G; Mohammedi I; Chidiac C; Peyramond D; Vandenesch F; Etienne J
Clin Microbiol Infect; 2008 Jun; 14(6):546-54. PubMed ID: 18373692
[TBL] [Abstract][Full Text] [Related]
12. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production.
Leung DY; Gately M; Trumble A; Ferguson-Darnell B; Schlievert PM; Picker LJ
J Exp Med; 1995 Feb; 181(2):747-53. PubMed ID: 7836926
[TBL] [Abstract][Full Text] [Related]
13. Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.
Sano S; Matsui Y; Itami S; Yoshikawa K
Clin Exp Immunol; 1998 Aug; 113(2):190-7. PubMed ID: 9717967
[TBL] [Abstract][Full Text] [Related]
14. Superantigens Modulate Bacterial Density during Staphylococcus aureus Nasal Colonization.
Xu SX; Kasper KJ; Zeppa JJ; McCormick JK
Toxins (Basel); 2015 May; 7(5):1821-36. PubMed ID: 26008236
[TBL] [Abstract][Full Text] [Related]
15. Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder.
Kadin ME; Hamilton RG; Vonderheid EC
PLoS One; 2020; 15(2):e0228751. PubMed ID: 32049976
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes.
Davison S; Allen M; Vaughan R; Barker J
Clin Exp Immunol; 2000 Aug; 121(2):181-6. PubMed ID: 10931129
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus superantigens and airway disease.
Bachert C; Gevaert P; van Cauwenberge P
Curr Allergy Asthma Rep; 2002 May; 2(3):252-8. PubMed ID: 11918868
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
Vadivel CK; Willerslev-Olsen A; Namini MRJ; Zeng Z; Yan L; Danielsen M; Gluud M; Pallesen EMH; Wojewoda K; Osmancevic A; Hedebo S; Chang YT; Lindahl LM; Koralov SB; Geskin LJ; Bates SE; Iversen L; Litman T; Bech R; Wobser M; Guenova E; Kamstrup MR; Ødum N; Buus TB
Blood; 2024 Apr; 143(15):1496-1512. PubMed ID: 38170178
[TBL] [Abstract][Full Text] [Related]
20. CD8+ Sézary syndrome with interleukin-22 production modulated by bacterial sepsis.
Shimauchi T; Sasada K; Kito Y; Mori T; Hata M; Fujiyama T; Ito T; Hirakawa S; Tokura Y
Br J Dermatol; 2013 Apr; 168(4):881-3. PubMed ID: 23013419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
